Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas
Clinical trial NCT01595321 · COMPLETED
Trial details
- NCT number
- NCT01595321
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-29
- Primary completion
- 2023-10-18
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.